Skip to content

Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients

Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01550042
Acronym
SCARF
Enrollment
4
Registered
2012-03-09
Start date
2011-09-30
Completion date
2015-04-30
Last updated
2024-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Stroke

Brief summary

Recent studies demonstrated that prolonged rhythm observation increases the detection of atrial fibrillation in patients prior diagnosed as cryptogenic stroke. Detection of atrial fibrillation in these patients has important therapeutic implications for the anticoagulation regimen. However, data on optimal monitoring duration and method of AF detection are limited.

Interventions

None listed

Sponsors

Medisch Spectrum Twente
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \> 18 years of age Recent episode (≤60 days) of cryptogenic ischemic stroke * Undetermined etiology with negative evaluation (including cardioembolism work- up) according to the criteria for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) * Implantation of an implantable loop recorder within two months after index event * Able of providing informed consent

Exclusion criteria

* Pre-existing indication for vitamin K antagonist * Untreated hyperthyroidism * Indication for pacemaker implantation, implantable cardioverter defibrillator (ICD) or Cardiac Resynchronisation Therapy (CRT) * Severe co-morbidity not likely to complete follow-up for one year

Design outcomes

Primary

MeasureTime frameDescription
Documented Atrial Fibrillation (AF)One yearThe percentage of patients with documented AF based on implantable cardiac monitor registration during a follow-up period of at least 12 months after an episode of cryptogenic stroke.

Secondary

MeasureTime frameDescription
Time to documented AFOne yearTime to documented AF using an Implantable Loop Recorder (ILR) data
Recurrent strokeOne yearIncidence of recurrent stroke

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026